Summary
Advances in HIV-1 envelope glycoprotein (Env) design generate native-like trimers and high-resolution clade A, B, and G structures and elicit neutralizing antibodies. However, a high-resolution clade C structure is critical, as this subtype accounts for the majority of HIV infections worldwide, but well-ordered clade C Env trimers are more challenging to produce due to their instability. Based on targeted glycine substitutions in the Env fusion machinery, we defined a general approach that disfavors helical transitions leading to post-fusion conformations, thereby favoring the pre-fusion state. We generated a stabilized, soluble clade C Env (16055 NFL) and determined its crystal structure at 3.9 Å. Its overall conformation is similar to SOSIP.664 and native Env trimers but includes a covalent linker between gp120 and gp41, an engineered 201-433 disulfide bond, and density corresponding to 22 N-glycans. Env-structure-guided design strategies resulted in multiple homogeneous cross-clade immunogens with the potential to advance HIV vaccine development.
Keywords: HIV, Envelope glycoprotein, bNAb, Antibody, Glycan shield, Vaccine, Trimer, Immunogen
Graphical Abstract

Highlights
-
•
Structure-guided design generates an HIV clade C Env crystal structure at 3.9 Å
-
•
Cross-clade Env comparison discloses overall structural and N-glycan conservation
-
•
The NFL structure reveals stabilizing TD contacts and the 201C-A433C disulfide CC
-
•
NFL Env redesign permits the generation of immunogens derived from clades A, B, and C
The majority of HIV-1 infections worldwide emanate from subtype C strains. Guenaga et al. describe the 3.9 Å crystal structure of a stabilized subtype C native, flexibly linked (NFL) Env and multiple structure-guided design strategies that permit the generation of Env immunogens from diverse HIV strains.
Introduction
A fundamental obstacle faced by all enveloped viruses is how to facilitate entry of their genetic material into susceptible host cells across two lipid bilayers. Most enveloped viruses converge upon a post-fusion “six-helix bundle” conformation of their envelope glycoproteins (Env) to accomplish fusion of the viral and host lipid bilayers, thereby facilitating entry of their genetic material into susceptible target cells (reviewed in Colman and Lawrence [2003]). Metastability is a requisite of envelope glycoproteins in terms of folding and assembly of a structure that can rearrange at the appropriate time to attain its fusion-active form. Extended helical transitional intermediates are generated for viral fusion proteins after receptor and co-receptor engagement, either at the cell surface or at the lower pH of the endosome, propelling the fusion peptide to the opposite end of the trimer for insertion into the target cell membrane (reviewed in Eckert and Kim, 2001]). Subsequently, the transitional intermediate collapses into a six-helix bundle, juxtaposing the viral and host cell membranes, allowing formation of a fusion pore that enables entry of the viral genetic material into the target cell.
For HIV, the Env is the sole neutralization target for antibodies on the viral surface and thus is of major interest for vaccine design. For decades, the generation of soluble mimics of Env was challenging due to its inherent metastability, in part because of the non-covalent association of the Env subunits, gp120 and gp41, due to furin cleavage of the precursor gp160 during natural infection to attain its fusion-active conformation (Berger et al., 1991, Moore et al., 1990). An engineered disulfide linking the two subunits and a key mutation, I559P, in heptad repeat 1 (HR1) resulted in the first native-like Env soluble mimic, the SOSIP trimer (Binley et al., 2000, Sanders et al., 2002). However, it was not until the generation of the subtype-A-derived BG505 SOSIP.664, with accompanying antigenicity, stability, and high-resolution structural data, that these trimers became widely considered and utilized as faithful mimics of the HIV spike (Julien et al., 2013, Lyumkis et al., 2013, Sanders et al., 2013). SOSIP trimers have been derived from many other Env sequences but can result in mixtures of ordered and disordered oligomers that can be “rescued” either by negative or positive selection (Guenaga et al., 2015a, Julien et al., 2015, Pugach et al., 2015). The initial cryoelectron microscopy (cryo-EM) and crystal structures of clade A BG505 SOSIP.664 (Julien et al., 2013, Lyumkis et al., 2013, Pancera et al., 2014) have been followed by Env structures for subtypes B and G (Lee et al., 2016, Stewart-Jones et al., 2016). However, high-resolution clade-C-derived Env structures, the subtype that constitutes the vast majority of HIV infections worldwide, have not yet been obtained. In the past year, we reported the engineering of an uncleaved soluble Env mimic, the native, flexibly linked (NFL) trimer. This design includes the I559P mutation present in SOSIP trimers but uses an extended flexible linker to replace the furin cleavage site between the two Env subunits, rendering these trimers both covalently linked and cleavage independent (Sharma et al., 2015). The native-like NFL trimers display antigenic and biochemical characteristics comparable to SOSIP trimers but do not require cleavage of the two Env subunits by cellular or exogenous furins (Guenaga et al., 2015b, Sharma et al., 2015). Like the SOSIP, the NFL design works best on a subset of Env sequences and, in its original design, is particularly inefficient at generating high yields of trimers derived from clade C strains.
We engineered a soluble trimer based on an Indian subtype C HIV Env sequence, called 16055 NFL “TD,” where TD refers to the reversion of eight BG505-“trimer-derived” residues that substantially improve the propensity to form native-like trimers (Guenaga et al., 2015b). To improve further on the TD design, we introduced targeted glycine substitutions in gp41 at helix-to-coil transitions to disfavor the post-fusion state of Env to generate highly homogeneous, soluble NFL clade C trimers. Aided by these design advances, we derived the crystal structure of the disulfide-stabilized (I201C-A433C) 16055 NFL TD CC (T569G) trimer in complex with the broadly neutralizing antibodies (bNAbs), PGT124 and 35O22, at 3.9 Å resolution, providing a high-resolution Env structure derived from a subtype C primary isolate. Comparison of this new structure to the available subtype A, B, and G structures reveals overall similarities, as well as interesting strain-dependent differences. In the NFL trimer structure, electron density is present for at least one sugar moiety of the 22 N-glycans visible from the 29 potential N-glycosylation sites (PNGS) (n.b., the others are mainly in disordered loops). The complex structure also defines the details of PGT124 bNAb interactions with Env in the context of a well-ordered trimer. Aided by the structural analysis, additional trimer redesign integrating TD, CC, glycine targeting, and further structure-based single-amino-acid modifications resulted in the generation of highly stable and homogeneous NFL soluble Env mimics for multiple subtypes. These improved designs advance our understanding of HIV Env structural interactions and our capacity to generate well-ordered NFL Env trimers from different clinical isolates derived from multiple subtypes. These advances lay a foundation for further structure-guided modifications to improve trimer conformational homogeneity, stability, and yield, providing an expanded repertoire of clade C and other HIV vaccine candidate immunogens. In a related accompanying paper, the immunogenic properties of well-ordered 16055 NFL TD CC trimers were evaluated in non-human primates (Martinez-Murillo et al., 2017).
Results
Glycine Substitutions in gp41 Promote Soluble Env Trimer Formation
To generate clade C NFL Env glycoproteins amenable to crystallization, we pursued a strategy to promote well-ordered trimer formation. To disfavor the Env post-fusion state and consequently promote pre-fusion trimer formation, we introduced glycine substitutions into key coil-to-helix transitional areas of the gp41 subunit, guided by the pre-fusion high-resolution Env trimer structures (Figure 1A) (Garces et al., 2015, Gristick et al., 2016, Julien et al., 2013, Lyumkis et al., 2013, Pancera et al., 2014). Putative helical intermediates of Env are formed following receptor-coreceptor engagement, liberating gp41 from gp120-imposed conformational constraints. Because glycines disfavor helix formation, we substituted G residues at selected coil-to-helix junctions to inhibit conformational transitions to putative intermediate and structurally defined post-fusion, helix-dominated conformations. To test the glycine substitution strategy, we first generated NFL trimeric proteins based on the transmitted/founder subtype C South African HIV Env sequence, 1086c, introducing TD substitutions previously described (Guenaga et al., 2015b). TD stabilization alone was insufficient to generate native-like trimers for 1086c as determined by both SEC and EM (Figure 1B and Figure S1A), in contrast with their previous substantial impact on trimer formation for Indian clade C 16055 NFL and clade B JRFL NFL (Guenaga et al., 2015b).
Figure 1.
Env gp41 Glycine Substitutions Increase Native-like Trimer Formation
(A) Schematic model of the targeted glycine strategy to attenuate helical secondary structural transitions to the post-fusion form (left) and location of the tested glycine substitutions (red spheres) displayed on the crystal structure of the gp41 subunit in BG505 SOSIP.664 (PDB: 5CEZ) (right).
(B) SEC profiles of subtype C 1086c NFL TD variants with glycine substitutions at the indicated residues and TD as a control with no glycines. The vertical dotted red line denotes the elution volume of native-like, well-ordered trimers.
(C) SEC profiles of HIV-1 subtype C 16055 NFL TD trimers with and without T569G after lectin chromatography purification. Shown in the upper right is the SEC profile corresponding to a re-run of the trimer fractions. 2D class averages from negative-stain EM of the trimer fraction is shown below.
See also Figures S1 and S2.
To design more homogeneous 1086c NFL trimers and potentially for a wide range of trimers from multiple strains, we identified inferred coil-to-helix transitional regions in gp41 guided by the high-resolution structure of the pre-fusion BG505 SOSIP.664 and gp41 post-fusion structures (Buzon et al., 2010, Garces et al., 2015, Gristick et al., 2016, Julien et al., 2013, Liu et al., 2009, Lyumkis et al., 2013, Pancera et al., 2014). The pre-fusion gp41 regions of interest were located in the N-terminal HR1 loop (HR1N), which connects the central HR1 helix to the fusion peptide proximal region (FPPR), and in the region proximal to the N-glycan at residue 637 in HR2, where the HR2 helices bend to wrap around the gp120 N and C termini (Figure 1A). Crystal structures reveal that these coiled regions in gp41 transition to helices during the pre-fusion to the post-fusion state (Buzon et al., 2010, Shu et al., 2000, Tan et al., 1997). Therefore, within the context of the 1086c NFL TD protein that displays no significant amount of ordered trimers, we generated selected glycine substitutions to test their effect on ordered trimer formation. Residues T536, L537, L544, L568, T569, N636, and Y638 were individually substituted with glycines and evaluated by size exclusion chromatography (SEC), EM, and immunoprecipitation (IP). Following initial NFL glycoprotein purification by lectin-affinity chromatography, SEC profiles revealed a marked change in the proportions of monomeric, dimeric, and aggregated 1086c glycoproteins carrying the selected glycine substitutions (Figure 1B). 1086c NFL TD glycoproteins with glycine substitutions at positions 568 and 569 displayed the most improved trimer formation relative to the TD variant, with reduced monomer, dimer, and higher-order forms (Figure 1B). Substitutions at 544 and 636 showed moderate improvement, whereas substitutions at 536, 537, and 638 showed no improvement (Figure 1B).
EM negative-stain analysis of the trimeric proteins showed a marked increase in native-like trimers for variants with glycine substitutions at residues 568, 569, and 636 and moderately for 544, generally consistent with the SEC analysis (Figure S1A). IP of NFL TD protein supernatants using the CD4 binding site (CD4bs), trimer-preferring broadly neutralizing antibody (bNAb) VRC03, and the trimer-independent CD4bs bNAb, VRC01, yielded results consistent with the EM analysis. For example, stronger intensity VRC03 IP bands were detected for NFL TD variants with glycine substitutions at residues 568 and 569 compared to isogenic trimers lacking these changes (Figure S1B). We also evaluated various single-, double-, and triple-glycine combinations and concluded that single-L568G or -T569G and double-L568G-N636G or -T569G-N636G substitutions markedly improved the generation of well-ordered 1086c NFL TD trimers. Based on the VRC03 IP band intensity, triple combinations (T569G-L544G-N636G and L568G-L544G-N636G) did not appear to be better than the double substitutions and were not pursued further in this study (Figure S1B).
To assess the transferability of this strategy to other HIV Env sequences, we introduced the 1086c-effective T569G substitution into the JRFL NFL TD and 16055 NFL TD glycoproteins (Guenaga et al., 2015b) and assessed its effect on trimer homogeneity by SEC and differential scanning calorimetry (DSC). The T569G substitution greatly increased trimer formation and homogeneity in both clade B and C NFL TD contexts (Figures 1C, S1C, S2A, and S2B). The L568G mutation conferred similar results in the context of 16055 NFL TD as assessed by SEC and DSC, displaying comparable levels of homogeneity and stability (only 0.4°C less) (Figure S1C). In fact, with no additional purification except for isolation of the trimer fraction from the SEC, 98% of the 16055 NFL TD (T569G) trimers displayed a native-like conformation as determined by negative-stain EM (Figure 1C).
These results revealed that helix-disrupting glycine substitutions at critical helix-to-coil interfaces disfavor transitions toward the receptor-triggered putative HIV Env transitional intermediate and, specifically, that glycine substitutions at the HR1N residues 568 and 569 and HR2 residue 636 increased native-like Env trimer formation.
The Clade C Cleavage-Independent 16055 NFL TD CC T569G Trimer Shares Structural Homology with Clade A, B, and G Envs
Several HIV-1 subtype C Env-derived SOSIP and NFL trimers are well described biochemically and by low-resolution EM (Guenaga et al., 2015a, Guenaga et al., 2015b, Julien et al., 2015, Ringe et al., 2015, Sharma et al., 2015). However, no high-resolution structure of a soluble subtype C Env trimer has been determined. We therefore used the highly homogeneous T569G variant of 16055 NFL TD CC trimer to generate crystals that diffracted to 3.9 Å in complex with bNAbs PGT124 and 35O22 (Garces et al., 2014, Huang et al., 2014, Pancera et al., 2014). From this ternary complex, we were able to determine the crystal structure of a clade C Env NFL trimer by molecular replacement (see STAR Methods, Figure 2A, and Table 1).
Figure 2.
The Cleavage-Independent Subtype C HIV-1 Env 16055 NFL TD CC Trimer Shares Homology with Other Env Trimer Structures
(A) Crystal structure at 3.9 Å resolution of the 16055 NFL TD CC (T569G) trimer (gp120 purple, gp41 blue, PDB: 5UM8) in complex with Fabs PGT124 (brown) and 35O22 (orange).
(B) Superimposition of the gp120 subunits of soluble Env trimers derived from HIV-1 clade C NFL (magenta), clade A BG505 SOSIP.664 (gray, PDB: 5CEZ), clade G X1193.c1 SOSIP.664 (light orange, PDB: 5FYJ), and clade B JRFL Env ΔCT (green, PDB: 5FUU) (left). Corresponding overlap of the gp41 subunits of 16055 (blue), BG505 (gray), X1193.c1 (light orange), and JRFL Env (green) (middle). Close-up view of the HR1 region of the NFL trimer showing the T569G mutation and residues downstream that demarcate the region that undergoes the coil-to-helix transition in the post-fusion structure (right).
See also Figures S2 and S3.
Table 1.
Data Collection and Refinement Statistics
| Data collection | 16055 NFL TD CC (T569G) + PGT124 + 35O22 |
|---|---|
| Beamline | APS-23ID-D |
| Wavelength (Å) | 1.03320 |
| Space group | P63 |
| Unit cell parameters (Å) | a = b = 126.5, c = 314.1 |
| Resolution (Å) | 50.0-3.94 (4.02-3.94)a |
| Observations | 125,205 |
| Unique reflections | 25,153 (1,224) |
| Redundancy | 5.0 (4.9) |
| Completeness (%) | 100 (100) |
| <I > /<σI> | 7.5 (1.1) |
| CC1/2 (%)b | 92.3 (64.1) |
| Rsym (%)c | 19.4 (150.5) |
| Rpim (%)d | 9.6 (75.0) |
| Refinement statistics | |
| Resolution (Å) | 49.25-3.94 |
| Reflections (work) | 23,799 |
| Reflections (test) | 1,253 |
| Rcryst (%)e | 27.4 (37.7) |
| Rfree (%)f | 31.8 (39.1) |
| Average B-value (Å2) | |
| All protein atoms | 156 |
| gp120 | 126 |
| gp41 | 149 |
| PGT124 (VH/VL) | 140 |
| PGT124 (CL/CH1) | 150 |
| 35O22 (VH/VL) | 163 |
| 35O22 (CL/CH1) | 242 |
| Glycans | 155 |
| Wilson B-value (Å2) | 119 |
| RMSD from ideal geometry | |
| Bond length (Å) | 0.002 |
| Bond angles (°) | 0.58 |
| Clashscoreg | 6.6 |
| Ramachandran statistics (%) | |
| Favored | 90.6 |
| Outliers | 1.8 |
| PDB ID | PDB: 5UM8 |
Numbers in parentheses refer to the highest resolution shell.
CC1/2 = Pearson Correlation Coefficient between two random half datasets
Rsym = ΣhklΣi | Ihkl,i - < Ihkl> | / ΣhklΣiIhkl,I, where Ihkl,i is the scaled intensity of the ith measurement of reflection h, k, l, < Ihkl> is the average intensity for that reflection, and n is the redundancy (Weiss and Hilgenfeld, 1997).
Rpim is a redundancy-independent measure of the quality of intensity measurements. Rpim = Σhkl (1/(n-1))1/2 Σi | Ihkl,i - < Ihkl> | / Σhkl ΣiIhkl,I, where Ihkl,i is the scaled intensity of the ith measurement of reflection h, k, l, < Ihkl > is the average intensity for that reflection, and n is the redundancy.
Rcryst = Σhkl | Fo - Fc | / Σhkl | Fo | × 100
Rfree was calculated as for Rcryst, but on a test set comprising 5% of the data excluded from refinement.
Number of unfavorable all-atom steric overlaps ≥ 0.4Å per 1,000 atoms.
Overall, the structure of 16055 NFL TD CC (T569G) in complex with PGT124 and 35O22 closely resembles those of soluble subtype A BG505 SOSIP.664, subtype G X1193.c1 SOSIP.664, and full-length native subtype B JRFL Env ΔCT Env trimers (Figure 2B) (Garces et al., 2015, Julien et al., 2013, Lee et al., 2016, Pancera et al., 2014, Stewart-Jones et al., 2016). The similarity strengthens the interpretation that the engineered soluble NFL trimers, like SOSIP, are close mimics of HIV Env. The largest differences among Env structures were localized to variable regions V1, V2, V4, and V5 of gp120 and the HR1N region spanning residues 545–569 of gp41 (Figure S2C). With the exception of the V3, variable regions of gp120 differ both in length and conformation and contribute to antigenic variation with respect to antibody recognition (Figure S2C). The observed HR1N differences may be relevant to trimer stability and, perhaps, to the capacity of different Env sequences to form stable, soluble trimers, since the well-documented I559P substitution (Sanders et al., 2002) and the T569G described here are located in this flexible region, and both affect trimerization propensity (Figure S2C). Another difference in these NFL trimers is the flexible (G4S)2 linker connecting gp120 to gp41 that eliminates the need for furin cleavage (Sharma et al., 2015), for which only the first three glycine residues are visible in the NFL structure (Figure 2A).
Structural alignment between the BG505 SOSIP.664 and the 16055 NFL TD CC (T569G) structures revealed low Cα RMSD values for the gp140 protomer (0.7 Å) and the respective gp120 (0.6 Å) or gp41 (0.6 Å) subunits (Figure S3A). Although residues 553–565 of the gp41 HR1N were not resolved in the 16055 structure, L566, Q567, L568, and G569 downstream of the I559P substitution were interpretable and offer some insights into how the 569 glycine substitution contributed to the generation of stable clade C Env NFL trimers (Figure 2B). The orientation and location of these four residues (566–569) in 16055 NFL TD CC (T569G) deviate from that in the BG505 SOSIP.664 and X1193.c1 SOSIP structures (PDB: 5CEZ and PDB: 5FYJ) but follow an initial path more similar to that in the clade B JRFL Env ΔCT (PDB: 5FUU), although different in conformation (Figures 2B and S2C). The helix-disrupting capacity of the T569G mutation disfavors the extension of the HR1C helix, helping HR1N remain in its flexible coil form observed in the SOSIP structures (Figures 2B and S2C). The increase in NFL trimer formation may also result from generation of new local stabilizing contacts in the HR1N region; however, no increase in the overall trimer thermal transition midpoint (Tm) was detected (Figure S2A). Perhaps the glycine substitution simply decreases the tendency of this region to adopt a transitional intermediate form of gp41, therefore favoring the pre-fusion state.
These analyses demonstrated that the crystal structure of the furin-independent clade C Env 16055 NFL TD CC (T569G) shares overall structural homology with other Envs, revealing differences in the surface-exposed variable regions and in the more occluded trimer-axis proximal region of gp41 HR1N.
Env N-Glycosylation Differences between Strains Identify Potential Sites of Vulnerability for Antibody Recognition
HIV has evolved immune evasion mechanisms that pose a major challenge to vaccine design. Env surface N-glycosylation is an important evasion mechanism in which self-glycans occlude the underlying Env protein surface. With an average of 80–90 N-linked glycans per Env trimer, this protective coverage is often referred to as the “glycan shield” (Lasky et al., 1986, Wei et al., 2003). The 16055 NFL TD CC trimers were produced in a GnTI−/− mutant cell line that results in processing of N-glycans to Man5–9GlcNAc2 oligomannose forms. The ternary complex of PGT124:16055 NFL TD CC:35O22 was deglycosylated by Endoglycosidase H (Endo H) treatment to facilitate crystallization. At least one sugar moiety for 22 glycans was visible in the electron density maps out of the 29 potential N-linked glycosylation sites (PNGS) in the 16055 Env sequence. For 15 N-glycans out of the 22 visible in the structure, we observed density beyond the peptide-proximal N-acetylglucosamine moiety, indicating protection from Endo H cleavage. The other glycan positions for which we did not observe interpretable density were mainly in disordered regions or loops. In comparison, 17 glycans had observable electron density in the 27 PNGS of the 3Å structure of BG505 SOSIP.664 (Figure 3) (Garces et al., 2015). The V1 and C2 regions of 16055 were more heavily glycosylated, possessing five additional PNGSs at N138, N147, N230, N241, and N289. In contrast, the C3 region of BG505 had two additional potential glycosylation sites at N339 and N355 (Figure 3). Breaches in the glycan shield, such as those corresponding to N230-N241-N289 and N339-N355 for BG505 and 16055, respectively, may define strain-specific sites of vulnerability as recently shown for Env vaccine-elicited antibodies in rabbits (Crooks et al., 2015, Klasse et al., 2016, McCoy et al., 2016). Some of these rabbit antibodies neutralize the HIV BG505 strain by exploiting a gap in the glycan shield at the N241 region, thereby more readily accessing the exposed protein surface. However, the majority of HIV strains are glycosylated at N241, as is 16055, or possess a different protein sequence in this region, making them resistant to neutralization by such antibodies (Figure 4A).
Figure 3.
N-Glycosylation Sites in the 16055 NFL TD CC Structure Differ from Those in the BG505 SOSIP.664 Structure
(A) Schematic representation of the 16055 NFL and BG505 SOSIP trimer constructs, with all PNGS numbered on Env regions and those visible in either structure highlighted in green boxes.
(B) 16055 NFL TD CC (T569G) structure (top) with gp120 (magenta), gp41 (blue), and BG505 SOSIP.664 structure (where N137 was deleted) (bottom, gray) (PDB: 5CEZ) in cartoon representation, with visible N-glycans as green or blue spheres. Blue spheres represent glycans visible in the 16055 NFL TD CC (T569G) structure that are either not ordered in the BG505 SOSIP.664 structure or are not PNGS in BG505 Env, and the orange spheres represent the reverse in BG505 SOSIP.664.
Figure 4.
PGT124 Displays Broad Recognition of the Glycan Shield, while Autologous NAbs Exploit Gaps in the Shield
(A) 16055 NFL TD CC (T569G) structure with gp120 (magenta), gp41 (blue) (left), and BG505 SOSIP.664 structure (gray, right) in cartoon and surface-mode representation, with glycans as green or yellow spheres. Yellow spheres denote glycans present on 16055 Env that are not present in BG505 Env that produce a glycan hole that is targeted by vaccine-elicited antibodies (Klasse et al., 2016, McCoy et al., 2016).
(B) 16055 NFL TD CC (T569G) structure in cartoon representation (gp140 gray), with Fab PGT124 (brown) in surface mode and proximal N-glycans N156, N301, and N332 in green (left). Close-up view of the PGT124-interacting region, where the antibody heavy and light chains (dark and light brown, respectively) are represented as a cartoon and the Env gp120 subunit in gray with glycans in green sticks. Previously described antibody contacts [IG(D/N)IR] with a gp120 core are colored pink (Garces et al., 2014), while new contacts in the context of trimeric Env are colored purple, with the corresponding interacting antibody residues colored in magenta.
Almost all bNAbs isolated from infected patients, such as PGT124 that targets the 332 N-glycan and V3 base, incorporate glycans as part of their epitope, contacting a combination of sugar moieties and underlying protein residues (Figure 4B). In the 16055 crystal structure, PGT124 penetrates into a cleft surrounded by glycans N156, N301, and N332 (Figure 4B). The antibody mostly avoids the N-glycans at residues N156 and N301 but makes contact with N332 and the conserved V3 324G(N/D)IR327 motif as previously demonstrated for PGT124 in the context of a gp120 core (Garces et al., 2014). The NFL trimer structure shows additional van der Waals interactions between PGT124 CDRL3 (Ser93, Ser95), CDRH3 (Phe100k), and gp120 V1 (Thr137) and backbone contacts between CDRL3 (Arg94) and the base of gp120 V3 (Ile322) (Figure 4B). Phe100g at the tip of CDRH3 that is important for the neutralization activity of PGT124 in a paratope scan (Garces et al., 2014) interacts with Env Gln328, Tyr330, Thr415, and Pro417 (Figure 4B).
These data were consistent with the limited neutralizing capacity of strain-specific antibodies that exploit gaps in the HIV Env N-glycan shield, while bNAbs evolve to accommodate glycan recognition as a means to more consistently penetrate the shield.
The High-Resolution 16055 NFL Structure Reveals the Stabilizing Effects of the TD and CC Substitutions
The 16055 NFL trimer contains eight engineered TD residues, the CC disulfide, and the T569G glycine substitution. The NFL structure elucidated the role of these design elements in generating native-like trimers with increased stability (Guenaga et al., 2015b). We observed interactions for six of the eight TD residues located in four distinct areas of Env: gp120-gp41 interface (Arg500), gp120 N terminus (Asp47 and Glu49), pre-bridging sheet (Arg429 and Gln432), and apex domain (Leu165) (Figure S3B). The Arg500 substitution at the C terminus of gp120 contacts the adjacent gp41 His619 and gp120 N-terminal residues Gly32 and Leu34, strengthening the association of gp120 with gp41 at the base of the trimer. Asp47 and Glu49 in the N-terminal region of gp120 contact Lys487 and Asp99, respectively, anchoring this flexible region. Leu165 at the tip of the trimer V2 apex contacts Thr128 and Cys126 of the adjacent protomer, presumably strengthening apical trimer interactions. Arg429 and Gln432 contact Asn425, Thr202, and Leu116, creating a network of interactions that may stabilize the pre-bridging sheet (Figure S3B). TD Lys65 and Thr106 do not contribute to any obvious productive interactions.
The 16055 NFL TD CC (T569G) crystal structure illustrates formation of the I201C-A433C disulfide (CC) that was engineered to prevent CD4-induced trimer rearrangements and subsequent exposure of non-neutralizing epitopes (Figure 5A) (Guenaga et al., 2015b, Kwon et al., 2015). As the 16055 NFL TD CC (T569G) and BG505 SOSIP.664 trimer structures displayed similar conformations, with a Cα RSMD of 0.6 Å for gp120 (Figure S3A), the engineered CC does not appear to significantly alter the conformation of the pre-CD4 form of the CD4bs. This region constitutes a conserved neutralizing determinant, so maintenance of an unperturbed CD4bs is an important consideration for HIV vaccine design. Relevant to this latter point, affinity and avidity measurements for bNAb Fabs VRC01 and VRC06b to NFL TD trimers with and without the CC disulfide were of similar magnitude (Figure S4). For sCD4, although the overall KD values were the same, CD4 had a slightly faster on rate but faster off rate with the NFL TD CC trimers.
Figure 5.
The Engineered Disulfide I201C-A433C Prevents CD4-Induced Env Rearrangements, Locking Env in the Pre-fusion State
(A) 16055 NFL TD CC (T569G) protomer (gp120, magenta; and gp41, blue) showing the location of the engineered disulfide (CC) in the pre-bridging sheet region (β20–β21, gray), (β3, blue), (β2, red), and the C201-C433 disulfide (green) (left). Close-up view of the pre-bridging sheet region (middle) and the 2Fo-Fc electron density map contoured at 1.0σ of the gp120 subunit β21–β3 region showing formation of the CC disulfide (right).
(B) CD4-liganded core gp120 (sCD4 in green and gp120 in light brown, PDB: 3JWO) with bridging sheet region colored the same as in (A) (left). Close-up view of the bridging sheet, illustrating the swap of β2 and β3 and the displacement of Q428 by CD4 (middle). Diagrams of the two states of the bridging sheet, as seen in the NFL and SOSIP structures (purple) and in the CD4-bound gp120 core (light brown) (right).
(C) Superimposition of the CD4-unliganded NFL structure with that of the CD4-liganded gp120 core. Some of the gp120 elements in the proximity of the CD4 binding site adopt different conformations between the pre-fusion state (purple, NFL Env structure) and the CD4-liganded state (brown, gp120 core structure).
See also Figure S4.
Comparison of the gp120 subunit of the 16055 NFL TD CC (T569G) trimer structure with the CD4-liganded gp120 core (PDB: 3JWO) (Pancera et al., 2010) revealed differences between these two gp120 conformations, as previously described (Pancera et al., 2014) (Figures 5B and 5C). This comparison suggested a receptor-triggered model, whereby gp120 conformational changes culminate in the release of restraints on gp41. In this model, CD4 interaction with gp120 induces a displacement of the β20 and β21 loop, triggering Env rearrangements that lead to co-receptor engagement. Serine 42 of CD4 would “push” gp120 glutamine 428 (β20), facilitating release of β21 contacts with β3 (Figure 5B). The subsequent swap of β3 and β2 facilitates rearrangement of the variable domains (V1/V2), liberating the V3 region to engage with the co-receptor. However, the engineered CC disulfide specifically prevents dissociation of β21 from β3, acting as a molecular tether that locks gp120 into its pre-receptor conformation (Figure 5A). Other structural differences were observed that connect the CD4-bound trigger point (β20-β21) with release of gp41 HR1 from gp120. Helix α-1 in the CD4-liganded core was tilted a few degrees toward the adjacent α-0 (Figure 5C), suggesting that CD4 receptor and subsequent CCR5 coreceptor binding trigger a chain of events that lead to the formation of a putative intermediate Env structure.
In sum, these analyses demonstrated that the TD, CC, and T569G mutations combine to preserve the pre-fusion state of the NFL trimers by disfavoring conformational changes in gp120 and gp41 that otherwise would favor the fusion-active form.
Targeting Additional HIV Env Metastable Regions Facilitates Generating NFL Trimers Derived from Several Subtypes
Metastability is likely a requisite for Env to mediate receptor-triggered viral entry at neutral pH. Regions of Env, such as the variable region 3 (V3) and the fusion peptide (FP), undergo large translational and conformational rearrangements following receptor-coreceptor engagement on target cells (Figure 6A) (Buzon et al., 2010, Luftig et al., 2006, Pancera et al., 2014). We sought to further stabilize the soluble NFL trimers beyond the stabilizing mutations described in the structure presented here by further reducing the inherent Env metastability. We reasoned that conformational stabilization of these trimeric immunogens might be important for preservation and presentation of quaternary-dependent neutralizing epitopes following vaccination and affinity maturation while avoiding Env states that expose non-neutralizing epitopes.
Figure 6.
The NFL TD CC+ Design Generates Homogeneous Stable Native-like Trimers
(A) Composite image depicting the conformational and translational changes that the V3 and FP undergo after cellular receptor triggering, before (blue) and after (green) receptor engagement are indicated. This image was derived from the following crystal structures: PDB: 5CEZ, Env trimer; PDB: 2B4C, triggered V3; and PDB: 2X7R, gp41 late fusion intermediate.
(B) DSC measurements of three NFL soluble trimers representing the three major HIV-1 subtypes A, B, and C (BG505, JRFL, and 16055, respectively) without and with V3-FP stabilization mutations (N302Y, F519R, and L520R).
(C) SEC profiles following lectin affinity chromatography of the NFL TD CC+ proteins.
(D) Bio-layer interferometry measuring NFL TD CC+ trimer interaction by selected trimer-preferring V2-apex bNAbs.
See also Figures S5 and S6.
We selected JRFL NFL TD CC (T569G) as a test case because of its inherent lower thermostability in comparison with BG505 or 16055 native-like trimers (Guenaga et al., 2015a, Guenaga et al., 2015b, Sharma et al., 2015). Following a structure-guided approach, a number of V3 or FP residues were scanned for their capacity to increase inter- or intra-protomer interactions. We made substitutions of selected residues in these regions to large side chains—mainly, Trp, Tyr, and Arg—to fill pockets or make potential additional contacts to enhance subunit and trimer interactions. The initial scan identified three V3-FP stabilizing mutations (V3 N302Y and FP F519R and L520R) that resulted in increased trimer melting temperatures. DSC analysis of the triple mutant (N302Y F519R L520R) JRFL NFL TD CC (T569G) confirmed a 6°C increase in the Tm (Figure 6B). We introduced the V3-FP mutations into subtype A BG505 NFL CC and subtype C 16055 NFL TD CC (T569G) and determined that their respective Tm’s also increased by 6°C (Figure 6B). By applying all elements of the current design strategy (TD, CC, gp41 glycines, and V3-FP mutations, herein called NFL TD CC+) to other HIV Env sequences from clades B (SC422 and WITO) and C (1086c, 001428 and ZM197M), we sought to demonstrate the general applicability of our soluble NFL TD CC+ trimer platform (Figure S5). The NFL TD CC+ design made use of double glycine substitutions, either G568-G636 or G569-G636, as needed to increase homogeneity of the highly stabilized trimers. The resulting NFL TD CC+ trimers were purified via lectin affinity followed by SEC and then subjected to DSC analysis to assess their overall stability and homogeneity. SEC profiles revealed prominent trimer peaks at the expected elution volume (Figure 6C), resulting in final yields of well-ordered trimers ranging from 2–4.5 mgs per liter of transfected 293F cells (Figure S5). Trimer stability, measured by DSC and reported as the Tm, ranged from 66°C to 77°C, displaying single narrow symmetric thermal transition curves that are characteristic of a homogeneous molecular species (Figure S6). Recognition of trimer-preferring V2-apex bNAbs (PGT145, PGDM1400, PG16, and VRC26), which bind one quaternary epitope per trimer, suggested that these soluble trimers adopted native-like conformations. Binding affinities for these ligands were determined by BLI and ranged from 2 to 205 nM (Figure 6D and Table S1). Generally, higher affinities (< 100nM) for NFL TD CC+ trimers were associated with neutralization of the matched parental HIV strain by that same bNAb, while lower binding affinities (> 100nM) were associated with an inability of that bNAb to neutralize the parental isolate from which the NFL was derived (Table S1).
These results indicated that combining the HIV Env stabilizing elements (TD, CC, glycines, and the V3-FP mutations) facilitated the high-yield production of cross-clade stable soluble NFL trimers that were efficiently recognized by trimer-specific bNAbs.
Discussion
Here, we described the design strategy and high-resolution crystal structure of a stabilized, soluble, subtype C HIV-1 Env trimer, 16055 NFL TD CC (T569G). The NFL protomer structure was virtually identical to that of subtype A BG505 SOSIP.664 and subtype G X1193.c1 SOSIP.664 soluble trimers and to subtype B native JRFL Env ΔCT, despite Env amino-acid-sequence variability in different subtypes and despite the fact that the NFL Env subunits, gp120 and gp41, are covalently linked by a flexible peptide linker. The structural differences were limited to the variable apex regions V1, V2, V4, and V5 in gp120, HR1N in gp41, and the glycan shield. Viral evolution, driven by immune selection pressure and accommodated by the error-prone reverse transcriptase, generates sequence diversity while conserving the key functional regions (receptor binding, fusion) that permit viral entry. Type I fusion proteins, such as the HIV-1 Env, mediate transfer of viral genetic material across the virus and host cell membranes to initiate replication. To carry out this vital function, fusion proteins adopt a highly metastable conformation in their pre-fusion state. Upon binding of receptor (and co-receptor), and sometimes exposure to low pH in endosomal compartments (e.g., influenza virus), large-scale Env conformational rearrangements are triggered, leading initially to extension of the long central helix (HR1C) that propels the fusion peptide toward and into the target cell. This state subsequently collapses to the post-fusion six-helix bundle, mediating viral-to-cell-membrane fusion. We made helix-disrupting glycine substitutions in strategically located gp41 residues that would disfavor such transitions. We selected junctional sites that transition from coils to helices in the post-fusion conformation to disrupt their helical potential. In doing so, we presumably decreased Env-free energy required to transition to the fusion intermediate, thereby favoring instead the pre-fusion state. The targeted T569G mutation was instrumental in improving the homogeneity of the soluble 16055 NFL TD CC trimer, perhaps by decreasing the propensity of gp41 to “spring” to undesired post-fusion conformations. The modified 16055 NFL generated diffraction-quality crystals that enabled structure determination.
The protein engineering in this study was tailored to generate soluble mimics of the HIV-1 envelope glycoprotein—in this case, the NFL trimer—but likely will work in the SOSIP platform, as we showed for the TD CC design elements (Guenaga et al., 2015b). The combination of stabilizing elements (TD, CC, and V3-FP mutations) and glycine substitutions allowed us to generate stable and homogeneous soluble mimics of Env derived from diverse HIV strains that can be used for both candidate immunogens and for structural studies. More importantly, the glycine modifications and other elements involved in the stabilization could be applied to other viral fusion proteins that undergo large conformational changes in transitioning from a pre-fusion to a post-fusion state. Another recent successful strategy has been to truncate the N-terminal HR1 region by substitution of a shorter connecting region that increases its stability and expression (Kong et al., 2016). In contrast, our strategy here focused on retaining the length of the N-terminal HR1 region and applying targeted glycine substitutions to inhibit helix extension and the subsequent “spring-loaded” gp41 rearrangement of its individual helices in HR1 and HR2 to a more stable six-bundle helical structure for fusion. Targeted substitution of helix-disrupting glycines disfavors formation of intermediate, receptor-activated forms of the viral envelope protein, increasing native-like trimer yields and homogeneity. The well-ordered 16055 NFL clade C trimers described here were evaluated as immunogens following vaccination of NHPs, as reported in an accompanying manuscript. This study found that the 16055 NFL TD CC trimers, when arrayed at high-density on liposomes, induced autologous tier 2 neutralizing antibodies, targeting the Env V2 apical region (Martinez-Murillo et al., 2017).
STAR★Methods
Key Resources Table
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Chemicals, Peptides, and Recombinant Proteins | ||
| 293fectin | Invitrogen | Cat#12347500 |
| Galanthus nivalis agarose | Vector Labs | Cat#AL-1243 |
| Endoglycosidase H | New England Biolabs | Cat#P0703L |
| R-Protein A Sepharose FF | GE Healthcare | Cat#17127903 |
| 1086c NFL TD | This paper | N/A |
| 1086c NFL TD (T536G) | This paper | N/A |
| 1086c NFL TD (L537G) | This paper | N/A |
| 1086c NFL TD (L544G) | This paper | N/A |
| 1086c NFL TD (L568G) | This paper | N/A |
| 1086c NFL TD (T569G) | This paper | N/A |
| 1086c NFL TD (N636G) | This paper | N/A |
| 1086c NFL TD (Y638G) | This paper | N/A |
| JRFL NFL TD (T569G) | This paper | N/A |
| 16055 NFL TD (T569G) | This paper | N/A |
| 16055 NFL TD CC (T569G) | This paper | N/A |
| 16055 NFL TD CC+ | This paper | N/A |
| JRFL NFL TD CC+ | This paper | N/A |
| BG505 NFL CC+ | This paper | N/A |
| SC422 NFL TD CC+ | This paper | N/A |
| WITO NFL TD CC+ | This paper | N/A |
| 1086c NFL TD CC+ | This paper | N/A |
| 001428 NFL TD CC+ | This paper | N/A |
| ZM197 NFL TD CC+ | This paper | N/A |
| Critical Commercial Assays | ||
| QuikChange Lightning Multi Site-Directed Mutagenesis Kit | Agilent Technologies | Cat#210513 |
| Deposited Data | ||
| 16055 NFL TD CC (T569G), 3.9 Å structure | This paper | PDB: 5UM8 |
| Experimental Models: Cell Lines | ||
| Human: FreeStyle 293F cells | Invitrogen | Cat#R79007 |
| Human: 293S (GnTi-) cells | ATCC | Cat#CRL-3022 |
| Software and Algorithms | ||
| ForteBio Data Analysis v7.1 | ForteBio | http://www.fortebio.com/octet-software.html |
| Coot | Emsley and Cowtan, 2004 | http://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/ |
| Leginon | Suloway et al., 2005 | http://emg.nysbc.org/redmine/projects/leginon/wiki/Leginon_Homepage |
| Appion | Lander et al., 2009 | http://emg.nysbc.org/redmine/projects/appion/wiki/Appion_Home |
| Clustering 2D Alignment | Sorzano et al., 2010 | http://xmipp.cnb.csic.es/twiki/bin/view/Xmipp/WebHome |
| IMAGIC | van Heel et al., 1996 | https://www.imagescience.de/imagic.html |
| PHENIX | Adams et al., 2010 | https://www.phenix-online.org |
| Other | ||
| Anti-human IgG Fc Capture (AHC) Biosensors | ForteBio | Cat#18-5060 |
| HiLoad 16/600 Superdex 200 pg column | GE Healthcare | Cat#28989335 |
| Superdex 200 Increase 10/300 GL column | GE Healthcare | Cat#28990944 |
| CaptureSelect LC-lambda (Hu) affinity matrix | ThermoFisher Scientific | Cat#084905 |
Contact for Reagent and Resource Sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Richard T. Wyatt (wyatt@scripps.edu).
Method Details
Design of NFL TD CC+ trimer constructs
HIV Env sequences (BG505, JRFL, SC422, WITO, 16055, 001428, ZM197M and 1086c (accession numbers DQ208458, U63632, AY835441, AY835451, EF117268, EF117266, DQ388515 and FJ444395, respectively) were modified to generate NFL TD CC+ soluble gp140 trimers as follows. The furin cleavage motif at the C terminus of gp120, “REKR,” was genetically deleted and replaced with two copies of the G4S (GGGGS) flexible linker, which covalently joins the C terminus of gp120 to the N terminus of gp41(Sharma et al., 2015). A proline substitution at residue 559 was introduced by genetic means to facilitate trimer formation (Sanders et al., 2002). The gp140 sequences were genetically terminated at D664 (Klasse et al., 2013) followed by a G4S linker, His6 tag, and stop codon. The 16055 NFL protein construct used for the crystallization study had a stop codon after residue D664. All Env sequences except BG505 were modified with TD (BG505-trimer derived) residues and selected gp41 glycine substitutions to generate more stable and homogeneous NFL TD trimers (see Figure S5 for specific substitutions)(Guenaga et al., 2015b). Finally, all NFL TD+ constructs, including BG505, were genetically engineered with a C201-C433 disulfide (Guenaga et al., 2015b, Kwon et al., 2015) and V3-FP stabilizing mutations (Y302, R519 and R520). Substitutions in the Env-derived NFL glycoproteins were introduced via site-directed mutagenesis PCR using a QuikChange Lightning Multi Site-Directed Mutagenesis kit (Agilent Technologies) into expression plasmid DNAs. Substitutions were confirmed by sequencing (Genewiz).
Expression and purification of soluble proteins
Expression plasmids (CMV-R) encoding the NFL trimeric Env-derived glycoproteins were transfected in FreeStyle 293F or 293S cells using 293fectin (Invitrogen). Cell culture supernatants were harvested five days post transfection and the Env-derived proteins purified by lectin affinity chromatography (Galanthus nivalis, Vector Labs) followed by size exclusion chromatography (SEC) on a Superdex 200 16/60 or Superdex 200 10/300 GL (GE Healthcare). Similarly, all Fabs were produced by transient transfection in FreeStyle 293F and purified by affinity chromatography on a CaptureSelect LC-lambda column (ThermoFisher Scientific), followed by cation exchange chromatography and SEC on a Superdex 200 16/60.
Sample preparation for crystallization
Crystallization screening required the testing of many combinations of ligand-16055 NFL TD CC (T569G) trimer complexes in different conditions. Generally, trimers and antibody ligands were mixed in a 1:3.2 molar ratio before SEC purification of the complex. To decrease heterogeneity on the NFL trimer:ligand complexes, NFL trimer produced in 293S cells was complexed with antibodies and then deglycosylated using Endoglycosidase H (EndoH; New England Biolabs) in 200 mM NaCl, 50 mM sodium citrate pH 5.5 for 45 min at 37°C (Julien et al., 2013). Glycans interacting with or protected by interaction with the Fabs are generally preserved in their ‘native’ forms (in this case high mannose due to the cell line used for expression), but those accessible to EndoH are trimmed to the core GlcNAc moiety.
Crystallization and data collection
To determine the molecular architecture of the 16055 NFL TD CC (T569G) Env trimer, we analyzed the soluble NFL trimer in a ternary complex with Fabs PGT124 and 35O22. These Fabs maintain the native trimer conformation and facilitate crystal packing (Garces et al., 2015). The purified ternary complex was concentrated to ∼12.2 mg/ml and screened in nearly 1000 crystallization conditions at 4 and 20°C using the IAVI/JCSG/TSRI CrystalMation robot (Rigaku) system at TSRI (Elsliger et al., 2010). Initial crystals were found in 0.2 M ammonium sulfate pH 4.5, 10% (v/v) glycerol, 20% (v/v) PEG 300 and 0.1 M phosphate-citrate pH 4.2. Optimized crystals were grown in 0.2 M ammonium sulfate, 10% (v/v) glycerol, 22% (v/v) PEG 300 and 0.1 M phosphate-citrate pH 4.03 and did not require further cryoprotection (as the 10% glycerol in the crystallization condition was sufficient). The crystals were then stored by immediate flash cooling in liquid nitrogen. Data were collected at APS beamline 23-ID-D. Although we observed some diffraction to 3.5 Å, the final dataset was processed with HKL-2000 (Otwinowski and Minor, 1997) to 3.9 Å with an overall Rsym of 0.23% and 100% completeness in space group P63 with unit cell parameters: a = b = 126.5 Å, c = 314.1 Å (Table 1).
Structure determination and refinement
For the ternary complex, two previous structures were used for phasing by MR: a protomer of 35O22:BG505 SOSIP.664 (PDB: 5CEZ) and the high-resolution unliganded PGT124 Fab (PDB: 4R26). Model building was carried out using Coot (Emsley and Cowtan, 2004) and refinement with phenix.refine using reference model restraints calculated from the structure of 35O22:BG505 SOSIP.664 (PDB: 5CEZ) and the PGT124 Fab (PDB: 4R26) (Adams et al., 2010). The final Rcryst and Rfree values are 27.4% and 31.8% (Table 1). For the Fabs, residues were numbered according to Kabat (Martin, 1996), and gp120/gp41 numbered following the HXBc2 system (Ratner et al., 1987).
Differential scanning calorimetry
The thermal transition points (Tm) of the NFL trimeric proteins were determined by differential scanning calorimetry (DSC) using a MicroCal VP-Capillary DSC instrument (Malvern). Prior to the DSC melting scan, the protein samples were extensively dialyzed in PBS, pH 7.4, and the concentrations were adjusted to 0.25 mg/ml. The dialysis buffer was used as the reference solution. The DSC experiments were done at a scanning rate of 1 K/min under 3.0 atmospheres of pressure. DSC data were analyzed after buffer correction, normalization, and baseline subtraction using MicroCal VP-Capillary DSC analysis software provided by the manufacturer.
Bio-Layer interferometry binding analysis
All binding measurements were carried out on an Octet Red instrument (ForteBio) with IgGs immobilized on anti-human IgG Fc capture sensors (ForteBio). The NFL trimers were assessed as free analytes in solution (PBS pH 7.4). For measurement of the V2-Apex bNAbs kinetic parameters, the analytes (NFL trimers) were concentrated to 800nM and then serially diluted 1:2 to a final concentration of 12.5nM. Association and dissociation times were 2 and 4 min respectively. Data were analyzed using the ForteBio analysis software version 7.1 (ForteBio) and the kinetic parameters were calculated using a global fit 1:1 model.
Electron microscopy and data collection
Following lectin purification, the NFL TD proteins were analyzed by negative-stain EM. A 3 μL aliquot containing ∼0.03 mg/mL of the sample was applied for 15 s onto a carbon-coated 400 Cu mesh grid that had been glow discharged at 15 mA for 30 s, then negatively stained with 2% uranyl formate for 50 s. Data were collected using a FEI Tecnai Spirit electron microscope operating at 120 kV, with an electron dose of ∼30 e-/Å2 and a magnification of 52,000 x that resulted in a pixel size of 2.05 Å at the specimen plane. Images were acquired with a Tietz 4k × 4k TemCam-F416 CMOS camera using a nominal defocus of 1000 nm and the Leginon package (Suloway et al., 2005).
Electron microscopy data processing
Particles were picked automatically using DoG Picker and put into a particle stack using the Appion software package (Lander et al., 2009, Voss et al., 2009). Reference-free, two-dimensional (2D) class averages were calculated using particles binned by two via the iterative msa/mra Clustering 2D Alignment and IMAGIC software systems and sorted into classes (Sorzano et al., 2010, van Heel et al., 1996). To analyze the quality of the trimers (closed, partially open, or non-native like trimers), reference-free 2D class averages were examined by visual inspection using the same metrics as previously described (Pugach et al., 2015).
Immunoprecipitation
Supernatants containing overexpressed NFL proteins were subjected to immunoprecipitation analysis to determine the relative amount of native-like trimers within the mixture. Briefly, 20 μL of rProtein A Sepharose beads (GE Healthcare) were added to an Eppendorf tube, washed twice with PBS, and resuspended in 500 μL of PBS. Selected antibodies were added to the tubes containing the agarose beads (5ug per antibody in separate tubes). The mixture was rocked for 30 min at 4°C and then washed twice with 500mM NaCl PBS to removed unbound antibody. Supernatants were aspirated without disturbing the beads and 1 mL of NFL protein containing filtered supernatant was added to each tube. After one-hour incubation at RT, the tubes were centrifuged at 1000 g for 5 min and the supernatant containing unbound protein was discarded. The protein A-agarose pellets containing the bound antibody-Env complexes were washed twice with 1 mL of PBS and then resuspended in 20 μL of SDS-PAGE loading buffer. The protein complexes were resolved over an SDS-PAGE 4%–12% Bis Tris NuPAGE gel (Invitrogen) for 50 min at 200 V.
Data and Software Availability
The 16055 NFL TD CC (T569G) crystal structure has been deposited to the RCSB Protein Data Bank with accession number PDB: 5UM8.
Author Contributions
Project design by J.G., F.G., R.T.W., and I.A.W.; protein engineering and design by J.G. and R.T.W.; X-ray work and analysis by F.G., R.L.S., and I.A.W.; EM work by N.V. and A.B.W.; protein expression and purification J.G., V.D., B.C., and B.H.; DSC analysis by J.G. and B.H. Manuscript written or edited by J.G., F.G., A.B.W., R.T.W., and I.A.W.
Acknowledgments
This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery (CAVD OPP1084519) (J.G., I.A.W., A.B.W., and R.T.W.). IAVI’s work is made possible by generous support from many donors, including the following: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. We are very grateful to H. Tien for crystallization screening. X-ray data sets were collected at the GM/CA@APS-23ID-D beamline, which has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This work was supported by the Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) UM1 AI00663 (A.B.W., I.A.W., and R.T.W.), by NIH P01 HIVRAD AI104722 (R.T.W.), by NIH R56 AI084817 (I.A.W.) and by the Joint Center of Structural Genomics (JCSG) funded by the NIH NIGMS Protein Structure Initiative U54 GM094586 (I.A.W.).
Published: May 16, 2017
Footnotes
Supplemental Information includes six figures and one table and can be found with this article online at http://dx.doi.org/10.1016/j.immuni.2017.04.014.
Contributor Information
Ian A. Wilson, Email: wilson@scripps.edu.
Richard T. Wyatt, Email: wyatt@scripps.edu.
Supplemental Information
References
- Adams P.D., Afonine P.V., Bunkóczi G., Chen V.B., Davis I.W., Echols N., Headd J.J., Hung L.W., Kapral G.J., Grosse-Kunstleve R.W. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berger E.A., Lifson J.D., Eiden L.E. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc. Natl. Acad. Sci. USA. 1991;88:8082–8086. doi: 10.1073/pnas.88.18.8082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Binley J.M., Sanders R.W., Clas B., Schuelke N., Master A., Guo Y., Kajumo F., Anselma D.J., Maddon P.J., Olson W.C., Moore J.P. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 2000;74:627–643. doi: 10.1128/jvi.74.2.627-643.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buzon V., Natrajan G., Schibli D., Campelo F., Kozlov M.M., Weissenhorn W. Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions. PLoS Pathog. 2010;6:e1000880. doi: 10.1371/journal.ppat.1000880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Colman P.M., Lawrence M.C. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell Biol. 2003;4:309–319. doi: 10.1038/nrm1076. [DOI] [PubMed] [Google Scholar]
- Crooks E.T., Tong T., Chakrabarti B., Narayan K., Georgiev I.S., Menis S., Huang X., Kulp D., Osawa K., Muranaka J. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site. PLoS Pathog. 2015;11:e1004932. doi: 10.1371/journal.ppat.1004932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eckert D.M., Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 2001;70:777–810. doi: 10.1146/annurev.biochem.70.1.777. [DOI] [PubMed] [Google Scholar]
- Elsliger M.A., Deacon A.M., Godzik A., Lesley S.A., Wooley J., Wüthrich K., Wilson I.A. The JCSG high-throughput structural biology pipeline. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2010;66:1137–1142. doi: 10.1107/S1744309110038212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- Garces F., Sok D., Kong L., McBride R., Kim H.J., Saye-Francisco K.F., Julien J.P., Hua Y., Cupo A., Moore J.P. Structural evolution of glycan recognition by a family of potent HIV antibodies. Cell. 2014;159:69–79. doi: 10.1016/j.cell.2014.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garces F., Lee J.H., de Val N., de la Pena A.T., Kong L., Puchades C., Hua Y., Stanfield R.L., Burton D.R., Moore J.P. Affinity maturation of a potent family of HIV antibodies is primarily focused on accommodating or avoiding glycans. Immunity. 2015;43:1053–1063. doi: 10.1016/j.immuni.2015.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gristick H.B., von Boehmer L., West A.P., Jr., Schamber M., Gazumyan A., Golijanin J., Seaman M.S., Fätkenheuer G., Klein F., Nussenzweig M.C., Bjorkman P.J. Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site. Nat. Struct. Mol. Biol. 2016;23:906–915. doi: 10.1038/nsmb.3291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guenaga J., de Val N., Tran K., Feng Y., Satchwell K., Ward A.B., Wyatt R.T. Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties. PLoS Pathog. 2015;11:e1004570. doi: 10.1371/journal.ppat.1004570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guenaga J., Dubrovskaya V., de Val N., Sharma S.K., Carrette B., Ward A.B., Wyatt R.T. Structure-guided redesign increases the propensity of HIV Env to generate highly stable soluble trimers. J. Virol. 2015;90:2806–2817. doi: 10.1128/JVI.02652-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang J., Kang B.H., Pancera M., Lee J.H., Tong T., Feng Y., Imamichi H., Georgiev I.S., Chuang G.Y., Druz A. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface. Nature. 2014;515:138–142. doi: 10.1038/nature13601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Julien J.P., Cupo A., Sok D., Stanfield R.L., Lyumkis D., Deller M.C., Klasse P.J., Burton D.R., Sanders R.W., Moore J.P. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science. 2013;342:1477–1483. doi: 10.1126/science.1245625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Julien J.P., Lee J.H., Ozorowski G., Hua Y., Torrents de la Peña A., de Taeye S.W., Nieusma T., Cupo A., Yasmeen A., Golabek M. Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens. Proc. Natl. Acad. Sci. USA. 2015;112:11947–11952. doi: 10.1073/pnas.1507793112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klasse P.J., Depetris R.S., Pejchal R., Julien J.P., Khayat R., Lee J.H., Marozsan A.J., Cupo A., Cocco N., Korzun J. Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein. J. Virol. 2013;87:9873–9885. doi: 10.1128/JVI.01226-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klasse P.J., LaBranche C.C., Ketas T.J., Ozorowski G., Cupo A., Pugach P., Ringe R.P., Golabek M., van Gils M.J., Guttman M. Sequential and simultaneous immunization of rabbits with HIV-1 envelope glycoprotein SOSIP.664 trimers from clades A, B and C. PLoS Pathog. 2016;12:e1005864. doi: 10.1371/journal.ppat.1005864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kong L., He L., de Val N., Vora N., Morris C.D., Azadnia P., Sok D., Zhou B., Burton D.R., Ward A.B. Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability. Nat. Commun. 2016;7:12040. doi: 10.1038/ncomms12040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kwon Y.D., Pancera M., Acharya P., Georgiev I.S., Crooks E.T., Gorman J., Joyce M.G., Guttman M., Ma X., Narpala S. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat. Struct. Mol. Biol. 2015;22:522–531. doi: 10.1038/nsmb.3051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lander G.C., Stagg S.M., Voss N.R., Cheng A., Fellmann D., Pulokas J., Yoshioka C., Irving C., Mulder A., Lau P.W. Appion: an integrated, database-driven pipeline to facilitate EM image processing. J. Struct. Biol. 2009;166:95–102. doi: 10.1016/j.jsb.2009.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lasky L.A., Groopman J.E., Fennie C.W., Benz P.M., Capon D.J., Dowbenko D.J., Nakamura G.R., Nunes W.M., Renz M.E., Berman P.W. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science. 1986;233:209–212. doi: 10.1126/science.3014647. [DOI] [PubMed] [Google Scholar]
- Lee J.H., Ozorowski G., Ward A.B. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer. Science. 2016;351:1043–1048. doi: 10.1126/science.aad2450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu J., Deng Y., Dey A.K., Moore J.P., Lu M. Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation. Biochemistry. 2009;48:2915–2923. doi: 10.1021/bi802303b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luftig M.A., Mattu M., Di Giovine P., Geleziunas R., Hrin R., Barbato G., Bianchi E., Miller M.D., Pessi A., Carfí A. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. Nat. Struct. Mol. Biol. 2006;13:740–747. doi: 10.1038/nsmb1127. [DOI] [PubMed] [Google Scholar]
- Lyumkis D., Julien J.P., de Val N., Cupo A., Potter C.S., Klasse P.J., Burton D.R., Sanders R.W., Moore J.P., Carragher B. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science. 2013;342:1484–1490. doi: 10.1126/science.1245627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin A.C. Accessing the Kabat antibody sequence database by computer. Proteins. 1996;25:130–133. doi: 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
- Martinez-Murillo P., Tran K., Guenaga J., Lindgren G., Àdori M., Feng Y., Phad G.E., Bernat N.V., Bale S., Ingale J. Particulate array of well-ordered HIV clade C Env trimers elicits neutralizing antibodies that display a unique V2 cap approach. Immunity. 2017;46:804–817. doi: 10.1016/j.immuni.2017.04.021. this issue. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCoy L.E., van Gils M.J., Ozorowski G., Messmer T., Briney B., Voss J.E., Kulp D.W., Macauley M.S., Sok D., Pauthner M. Holes in the glycan shield of the native HIV envelope are a target of trimer-elicited neutralizing antibodies. Cell Rep. 2016;16:2327–2338. doi: 10.1016/j.celrep.2016.07.074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moore J.P., McKeating J.A., Weiss R.A., Sattentau Q.J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science. 1990;250:1139–1142. doi: 10.1126/science.2251501. [DOI] [PubMed] [Google Scholar]
- Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
- Pancera M., Majeed S., Ban Y.E., Chen L., Huang C.C., Kong L., Kwon Y.D., Stuckey J., Zhou T., Robinson J.E. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proc. Natl. Acad. Sci. USA. 2010;107:1166–1171. doi: 10.1073/pnas.0911004107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pancera M., Zhou T., Druz A., Georgiev I.S., Soto C., Gorman J., Huang J., Acharya P., Chuang G.Y., Ofek G. Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature. 2014;514:455–461. doi: 10.1038/nature13808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pugach P., Ozorowski G., Cupo A., Ringe R., Yasmeen A., de Val N., Derking R., Kim H.J., Korzun J., Golabek M. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene. J. Virol. 2015;89:3380–3395. doi: 10.1128/JVI.03473-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ratner L., Fisher A., Jagodzinski L.L., Mitsuya H., Liou R.S., Gallo R.C., Wong-Staal F. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retroviruses. 1987;3:57–69. doi: 10.1089/aid.1987.3.57. [DOI] [PubMed] [Google Scholar]
- Ringe R.P., Yasmeen A., Ozorowski G., Go E.P., Pritchard L.K., Guttman M., Ketas T.A., Cottrell C.A., Wilson I.A., Sanders R.W. Influences on the design and purification of soluble, recombinant native-like HIV-1 envelope glycoprotein trimers. J. Virol. 2015;89:12189–12210. doi: 10.1128/JVI.01768-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanders R.W., Vesanen M., Schuelke N., Master A., Schiffner L., Kalyanaraman R., Paluch M., Berkhout B., Maddon P.J., Olson W.C. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J. Virol. 2002;76:8875–8889. doi: 10.1128/JVI.76.17.8875-8889.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanders R.W., Derking R., Cupo A., Julien J.P., Yasmeen A., de Val N., Kim H.J., Blattner C., de la Peña A.T., Korzun J. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 2013;9:e1003618. doi: 10.1371/journal.ppat.1003618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sharma S.K., de Val N., Bale S., Guenaga J., Tran K., Feng Y., Dubrovskaya V., Ward A.B., Wyatt R.T. Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design. Cell Rep. 2015;11:539–550. doi: 10.1016/j.celrep.2015.03.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shu W., Liu J., Ji H., Radigen L., Jiang S., Lu M. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides. Biochemistry. 2000;39:1634–1642. doi: 10.1021/bi9921687. [DOI] [PubMed] [Google Scholar]
- Sorzano C.O., Bilbao-Castro J.R., Shkolnisky Y., Alcorlo M., Melero R., Caffarena-Fernández G., Li M., Xu G., Marabini R., Carazo J.M. A clustering approach to multireference alignment of single-particle projections in electron microscopy. J. Struct. Biol. 2010;171:197–206. doi: 10.1016/j.jsb.2010.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart-Jones G.B., Soto C., Lemmin T., Chuang G.Y., Druz A., Kong R., Thomas P.V., Wagh K., Zhou T., Behrens A.J. Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G. Cell. 2016;165:813–826. doi: 10.1016/j.cell.2016.04.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Suloway C., Pulokas J., Fellmann D., Cheng A., Guerra F., Quispe J., Stagg S., Potter C.S., Carragher B. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 2005;151:41–60. doi: 10.1016/j.jsb.2005.03.010. [DOI] [PubMed] [Google Scholar]
- Tan K., Liu J., Wang J., Shen S., Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. USA. 1997;94:12303–12308. doi: 10.1073/pnas.94.23.12303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Heel M., Harauz G., Orlova E.V., Schmidt R., Schatz M. A new generation of the IMAGIC image processing system. J. Struct. Biol. 1996;116:17–24. doi: 10.1006/jsbi.1996.0004. [DOI] [PubMed] [Google Scholar]
- Voss N.R., Yoshioka C.K., Radermacher M., Potter C.S., Carragher B. DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. J. Struct. Biol. 2009;166:205–213. doi: 10.1016/j.jsb.2009.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S. Antibody neutralization and escape by HIV-1. Nature. 2003;422:307–312. doi: 10.1038/nature01470. [DOI] [PubMed] [Google Scholar]
- Weiss M.S., Hilgenfeld R. On the use of the merging R factor as a quality indicator for X-ray data. J. Appl. Cryst. 1997;30:203–205. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






